Drug Type Regulated induced proximity targeting chimeras (RIPTAC) |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Halda Therapeutics LLCStartup |
Active Organization Halda Therapeutics LLCStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hormone Receptor Positive Breast Adenocarcinoma | Preclinical | US | Halda Therapeutics LLCStartup | 30 Sep 2024 |